Docosanol - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for docosanol and what is the scope of patent protection?

Docosanol is the generic ingredient in two branded drugs marketed by Haleon Us Holdings, Alembic, Aurobindo Pharma Ltd, P And L, P And L Development, and Taro, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for docosanol. Thirty-nine suppliers are listed for this compound.

Summary for docosanol

US Patents:	0
Tradenames:	2
Applicants:	6
NDAs:	6
Drug Master File Entries:	5
Finished Product Suppliers / Packagers:	39
Raw Ingredient (Bulk) Api Vendors:	122
Clinical Trials:	1
Patent Applications:	9,710
Drug Prices:	Drug price trends for docosanol
What excipients (inactive ingredients) are in docosanol?	docosanol excipients list
DailyMed Link:	docosanol at DailyMed

See drug prices for docosanol

Recent Clinical Trials for docosanol

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Ecogene 21	Phase 2
Laboratoire Boreaderme Inc.	Phase 2

See all docosanol clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for docosanol

D06BB	Antivirals
D06B	CHEMOTHERAPEUTICS FOR TOPICAL USE
D06	ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D	Dermatologicals

US Patents and Regulatory Information for docosanol

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro	DOCOSANOL	docosanol	CREAM;TOPICAL	214454-001	Oct 26, 2023		OTC	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alembic	DOCOSANOL	docosanol	CREAM;TOPICAL	215839-001	May 3, 2022		OTC	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Ltd	DOCOSANOL	docosanol	CREAM;TOPICAL	217090-001	Mar 1, 2024		OTC	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for docosanol

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Haleon Us Holdings	ABREVA	docosanol	CREAM;TOPICAL	020941-001	Jul 25, 2000	⤷ Sign Up	⤷ Sign Up
Haleon Us Holdings	ABREVA	docosanol	CREAM;TOPICAL	020941-001	Jul 25, 2000	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.